Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases

Hiroyoshi Kunimoto, Takayuki Sakuma, Takuma Ohashi, Mayoko Shirafuta, Hiroshi Teranaka, Hideaki Nakajima · 2024

Read Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases by Hiroyoshi Kunimoto, Takayuki Sakuma, Takuma Ohashi, Mayoko Shirafuta, Hiroshi Teranaka, Hideaki Nakajima (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11647689.txt.

Description

Hiroyoshi Kunimoto and co-authors report two cases where a kidney drug also eased a blood disorder. Their 2024 report deals with low-risk myelodysplastic syndrome, a bone marrow fault that causes anemia. Both patients also had chronic kidney disease, which adds its own anemia.

The drug, daprodustat, is a pill first used for kidney anemia. It works by restoring a signal that tells the body to make more red blood cells. Options for the marrow disorder are few, and a pill that works evenly is wanted. In both cases the anemia improved on the drug. The authors present the pair as a hint worth testing in more patients, with care for safety as well.

Catalog record

CREATORHiroyoshi Kunimoto, Takayuki Sakuma, Takuma Ohashi, Mayoko Shirafuta, Hiroshi Teranaka, Hideaki Nakajima
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE12 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11647689

Browse the full library · About the Tower of Babel